Dunlevie Maternal-Fetal Medicine Center

Empowering an arc of research and discovery in maternal-fetal health.

Dunlevie Maternal-Fetal Medicine Center for Discovery, Innovation and Clinical Impact, established in 2021 through a philanthropic donation by Elizabeth and Bruce Dunlevie, reimagines high-risk obstetrics by launching a bold and comprehensive research program to transform the health of pregnant patients and their babies. The Center enhances the existing world-class maternal-fetal medicine and obstetrics program at Stanford Medicine by focusing research and new faculty hires on emerging priorities in the field.

News & Updates

Center Research

Priorities are based on four research areas: 

  • Basic Science Discovery
  • Prenatal Diagnosis and Fetal Therapy
  • Clinical Trials (Obstetrical, Medical, and Surgical)
  • Perinatal Epidemiology and Population Health

These research areas are supported by a dedicated Research Core that provides critical infrastructure in research administration, biostatistics, writing and communications, study coordination and laboratory expertise. The ultimate objective is to rapidly accelerate discovery in the science and practice of high-risk obstetrics for families locally, nationally, and globally, and to pursue research that crosses socioeconomic boundaries and advances health equity.

About the Center

 The momentous and transformative gift from Elizabeth and Bruce Dunlevie will allow us to advance Maternal-Fetal Medicine Science and Practice locally at Stanford, nationally and globally.  This gift will positively and profoundly impact the health and wellbeing of expectant mothers, children and families everywhere and for generations to come.

Yasser El-Sayed, MD
Center Director